€60.00
iPamorelin is a growth hormone releasing peptide that is known as one of the weaker ones due to its side effects being very friendly to GHRP. Now by “weaker” this does not mean “useless.” It still has very effective results, but it just means that the effect it has on the body is not as intense, resulting in a much more favourable situation for anyone that is planning to use this peptide. It was first made by a company called Novo Nordisk, and it eventually passed two clinical trials via Helsinn Therapeutics. While it did have potential to be a very promising compound, the results in the full trials were never finished and the project was abandoned. It’s not very easy to find in medical circles, but it is very commonly used in a lot of performance-based areas because it has effects and capabilities very similar to that of human growth hormone (HGH).





Reviews
There are no reviews yet.